department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tofacitinib · pharmadog

pharmadog
drugs
Tofacitinib

drug

patient view →

tofacitinib ER

Marketedupdated 2mo ago

by Sinotherapeutics Inc

Approved

community read0 votes

indications

investigational

IBD (Crohn's + UC)Rheumatoid Arthritis

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Tofacitinib

generic

tofacitinib

indication

Ulcerative Colitis

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval120 co-mentions · 60 sources
drugXELJANZ111 co-mentions · 60 sources
drugXELJANZ XR111 co-mentions · 60 sources
drugTOFACITINIB CITRATE111 co-mentions · 60 sources
tagSmall Molecule60 co-mentions · 60 sources
drugtofacitinib60 co-mentions · 60 sources
drugtofacitinib citrate ER60 co-mentions · 60 sources
companyAjanta Pharma Ltd7 co-mentions · 7 sources

Trials studying tofacitinib ER

phase3Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitisactive not recruitingn=118
—Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Projectcompletedn=10
phase2Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitiscompletedn=180
phase2A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitiscompletedn=3
—Korean Post-marketing Surveillance for Xeljanz XRrecruitingn=200
phase3Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritiscompletedn=302
phase4A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)recruitingn=65
—Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Swedenrecruitingn=120

more trials →